Cassia Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-8,222
| Closed | -$425K | – | 63 |
|
|
2024
Q3 | $425K | Buy |
8,222
+235
| +3% | +$12.2K | 0.28% | 51 |
|
|
2024
Q2 | $332K | Sell |
7,987
-3,792
| -32% | -$157K | 0.22% | 53 |
|
|
2024
Q1 | $639K | Buy |
11,779
+3,681
| +45% | +$200K | 0.42% | 45 |
|
|
2023
Q4 | $416K | Buy |
8,098
+167
| +2% | +$8.57K | 0.34% | 50 |
|
|
2023
Q3 | $460K | Buy |
7,931
+182
| +2% | +$10.6K | 0.38% | 37 |
|
|
2023
Q2 | $496K | Buy |
7,749
+1,660
| +27% | +$106K | 0.39% | 27 |
|
|
2023
Q1 | $422K | Sell |
6,089
-107
| -2% | -$7.42K | 0.34% | 24 |
|
|
2022
Q4 | $446K | Buy |
+6,196
| New | +$446K | 0.37% | 25 |
|
|
2021
Q4 | – | Sell |
-17,724
| Closed | -$1.05M | – | 78 |
|
|
2021
Q3 | $1.05M | Buy |
+17,724
| New | +$1.05M | 0.72% | 73 |
|